Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404609 · ClinicalTrials.gov registry record · NA
Rapid Non-Invasive Brain Stimulation for OCD (oTMS)
A NA study of OCD, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03404609 is a NA study of OCD that has completed, run by Stanford University. The registered enrollment target is 7 participants, below the 818-participant average among 18 other OCD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03404609, a NA study of OCD, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how cortical stimulation affects Obsessive-Compulsive Disorder (OCD) symptoms.
Conditions Studied
Interventions
- DEVICE MagPro X100 by MagVenture
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-25 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404609
The ClinicalTrials.gov registry entry for NCT03404609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 18 other OCD trials with a reported enrollment target (99% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 1 intervention - of which MagPro X100 by MagVenture is the first listed.
NCT03404609 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03404609 about?
NCT03404609 is a clinical study titled "Rapid Non-Invasive Brain Stimulation for OCD (oTMS)". The purpose of this study is to understand how cortical stimulation affects Obsessive-Compulsive Disorder (OCD) symptoms.
What is the current status of trial NCT03404609?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-08-25. Estimated completion is 2019-07-01.
What conditions does trial NCT03404609 study?
This clinical trial studies the following conditions: OCD.
What interventions are being tested in trial NCT03404609?
The interventions under investigation include: MagPro X100 by MagVenture (DEVICE).
Who is sponsoring clinical trial NCT03404609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404609 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for OCD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation for a Novel OCD Biomarker and Treatment
RECRUITING · NA
-
Personalized DBS for OCD Guided by Stereoencephalography Mapping
RECRUITING · NA
-
Neurostimulation Versus Therapy for Problems With Emotions
RECRUITING · NA
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
RECRUITING · NA
-
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
RECRUITING · NA
-
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.